PHGE stock forecast
Our latest prediction for BiomX, Inc.'s stock price was made on the Dec. 19, 2019 when the stock price was at 10.00$.
In the short term (2weeks), PHGE's stock price should underperform the market by -4.95%. During that period the price should oscillate between -10.53% and +8.85%.
In the medium term (3months), PHGE's stock price should underperform the market by -13.02%. During that period the price should oscillate between -24.66% and +6.02%.Get email alerts
About BiomX, Inc.
BiomX Ltd engages in developing bacteriophage-based therapies for the treatment and prevention of diseases stemming from dysbiosis of the microbiome. The company was founded in March 2015 and is headquartered in Ness Ziona, Israel.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.03$ per share.
The book value per share is 0.22$
Three months stock forecastDec. 19, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|